Shanghai MicroPort MedBot Group Co (2252.HK) Stock Price
Shanghai MicroPort MedBot Group Co Price
Over the last 4 years Shanghai MicroPort MedBot Group Co grew revenue by 300.1% annually, reaching 551.07 M CNY. For Shanghai MicroPort MedBot Group Co, the net margin of -45.3% is up versus -27,112.6% a few years ago. The consensus 12-month price target for Shanghai MicroPort MedBot Group Co is 24.25 CNY, about 33.8% above where the stock trades today. Of 11 analysts, 8 rate the stock a buy — an overall Buy consensus.
Shanghai MicroPort MedBot Group Co stock price
Shanghai MicroPort MedBot Group Co business model & stock analysis
Frequently asked questions about Shanghai MicroPort MedBot Group Co
Analysts currently set an average price target of 24.41 CNY for the Shanghai MicroPort MedBot Group Co stock (median: 24.25 CNY), implying +34.7 % versus the latest price. The consensus is based on 11 analyst ratings.
Shanghai MicroPort MedBot Group Co Analyst Price Targets 2026
11 analysts currently rate the Shanghai MicroPort MedBot Group Co stock: 8 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Shanghai MicroPort MedBot Group Co to generate revenue of 1.15 B CNY and earnings per share of 0.07 CNY.
Shanghai MicroPort MedBot Group Co Analyst Price Targets 2026
Converted at the current exchange rate, the Shanghai MicroPort MedBot Group Co share trades at 2.42 EUR (18.12 CNY).
The Shanghai MicroPort MedBot Group Co share (2252.HK) is listed on 1 stock exchanges, including: Hongkong (HKEX) (2252.HK).
The expected revenue of Shanghai MicroPort MedBot Group Co is 1.15 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Shanghai MicroPort MedBot Group Co is 71.45 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Shanghai MicroPort MedBot Group Co is currently 261.59. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Shanghai MicroPort MedBot Group Co stock.
The price-to-sales ratio (P/S) of Shanghai MicroPort MedBot Group Co is currently 16.19. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Shanghai MicroPort MedBot Group Co stock.
The Eulerpool Quality Score for Shanghai MicroPort MedBot Group Co is 3/10.
The ISIN of Shanghai MicroPort MedBot Group Co is CNE100004QP1. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Shanghai MicroPort MedBot Group Co is 2252.HK. The ticker symbol is used to trade Shanghai MicroPort MedBot Group Co shares on the stock exchange.
Shanghai MicroPort MedBot Group Co stock
Shanghai MicroPort MedBot Group Co Peer Group
Shanghai MicroPort MedBot Group Co Ticker
Shanghai MicroPort MedBot Group Co FIGI
All fundamentals and in-depth analysis of Shanghai MicroPort MedBot Group Co
Our stock analysis for Shanghai MicroPort MedBot Group Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shanghai MicroPort MedBot Group Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.